2004
DOI: 10.1016/j.abb.2004.03.004
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of phage display system and leech-derived tryptase inhibitor as a tool for understanding the serine proteinase specificities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
14
0

Year Published

2004
2004
2010
2010

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 53 publications
1
14
0
Order By: Relevance
“…In an attempt to use HiTI mutant library as a tool to study trypsin-like enzymes specificities, the HiTI gene fragment was cloned into the phagemid pCANTAB 5E, so that it could be further used in a combinatorial mutant library, by displaying it on a phage surface. A functional display of HiTI on phage tips was expected, based on previous results of other Kunitz type inhibitors [26,42,43]. Our strategy for constructing the library was to conserve the Arg at P1 position based on trypsin specificity for basic amino acids in this position, and to restrict the number of possible mutations, the Leu at P4' position was also maintained, only the P1', P2', P3' and P5' were randomized to allow the construction of a representative library.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In an attempt to use HiTI mutant library as a tool to study trypsin-like enzymes specificities, the HiTI gene fragment was cloned into the phagemid pCANTAB 5E, so that it could be further used in a combinatorial mutant library, by displaying it on a phage surface. A functional display of HiTI on phage tips was expected, based on previous results of other Kunitz type inhibitors [26,42,43]. Our strategy for constructing the library was to conserve the Arg at P1 position based on trypsin specificity for basic amino acids in this position, and to restrict the number of possible mutations, the Leu at P4' position was also maintained, only the P1', P2', P3' and P5' were randomized to allow the construction of a representative library.…”
Section: Discussionmentioning
confidence: 99%
“…The display and selection of antibody chains on phage surfaces are the most important application of this technology [20,21]. In addition, phage display libraries have been used successfully to define enzyme substrates [22], to increase the anticoagulant activity of proteins [23,24], and to select specific protease inhibitors [25][26][27][28][29][30]. Previously, we evaluated the expression, display and selection of LDTI (Leech Derived Tryptase Inhibitor) variants specific for thrombin [29], human neutrophil elastase and human plasmin [25].…”
Section: Introductionmentioning
confidence: 99%
“…in [6]). More recent examples include the leech-derived trypsin inhibitor (LDTI) [63,64], the mustard trypsin inhibitor II (MTI II) [65,66] and ecotin [67 ].…”
Section: Protease Inhibitorsmentioning
confidence: 99%
“…Inhibition was restricted to thrombin and trypsin, while factor Xa, plasma kallikrein and neutrophil elastase were not inhibited. This study was further extended [64], and highly specific inhibitors to plasmin and neutrophil elastase were selected. To improve plant defense against aphids (soft-bodied insects), MTI II was subjected to phage display selection against trypsin and chymotrypsin [65,66].…”
Section: Protease Inhibitorsmentioning
confidence: 99%
“…The inhibitors used to induce pleurisy were: LDTI-2PL, recombinant leech-derived tryptase inhibitor-2PL [21]; recombinant mutant aprotinin [22]; EIsynt, synthetic human neutrophil elastase inhibitor (Calbiochem-Novabiochem, CA, USA); BmTIs, Boophilus microplus trypsin inhibitors [23]. The proteinase inhibitors used in the radioimmunoassay were: E-64, trans-epoxysuccinyl-L-leucyl-amido-(4-guanidino)butane (Calbiochem-Novabiochem); EDTA, ethylenediaminetetracetic acid (Gibco BRL, Life Technologies, NY, USA); captopril (Sigma, MO, USA); SBTI, soybean trypsin inhibitor (Amersham Biosciences, Uppsala); aprotinin (kindly donated by Ennes A. Auerswald [22]); dexamethasone (DecadronR, Prodome, NJ, USA); and E-carrageenan (Sigma).…”
Section: Drugsmentioning
confidence: 99%